GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 355 filers reported holding GLOBUS MED INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $303,000 | -96.2% | 5,405 | -94.9% | 1.28% | -90.5% |
| Q1 2022 | $7,896,000 | -70.7% | 107,024 | -71.3% | 13.40% | -23.8% |
| Q4 2021 | $26,949,000 | -40.3% | 373,254 | -36.6% | 17.58% | -28.8% |
| Q3 2021 | $45,137,000 | -46.3% | 589,100 | -45.7% | 24.71% | +144.1% |
| Q2 2021 | $84,118,000 | +135.8% | 1,084,979 | +87.6% | 10.12% | +166.3% |
| Q1 2021 | $35,668,000 | -39.8% | 578,371 | -36.4% | 3.80% | -31.3% |
| Q4 2020 | $59,282,000 | -11.7% | 908,953 | -30.8% | 5.54% | -16.6% |
| Q3 2019 | $67,130,000 | +307.2% | 1,313,177 | +136.7% | 6.64% | +264.4% |
| Q3 2017 | $16,486,000 | -82.5% | 554,699 | -80.4% | 1.82% | -83.5% |
| Q2 2017 | $93,980,000 | +8.1% | 2,835,000 | -3.4% | 11.07% | +21.5% |
| Q1 2017 | $86,935,000 | +88.3% | 2,935,000 | +57.8% | 9.11% | +79.7% |
| Q4 2016 | $46,165,000 | +10.0% | 1,860,000 | 0.0% | 5.07% | +25.5% |
| Q3 2016 | $41,980,000 | – | 1,860,000 | – | 4.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 908,953 | $59,282,000 | 5.54% |
| Sterling Investment Advisors, Ltd. | 234,623 | $15,302,000 | 5.20% |
| Next Capital Management LLC | 111,098 | $7,246,000 | 5.10% |
| Godshalk Welsh Capital Management, Inc. | 77,085 | $5,027,000 | 3.71% |
| Pembroke Management, LTD | 613,931 | $40,041,000 | 3.36% |
| XXEC, Inc. | 52,800 | $3,444,000 | 2.71% |
| Global Alpha Capital Management Ltd. | 302,377 | $19,721,000 | 2.42% |
| Van Berkom & Associates Inc. | 1,572,303 | $102,546,000 | 2.35% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 581,700 | $37,939,000 | 2.27% |
| RTW INVESTMENTS, LP | 1,640,859 | $107,017,000 | 1.80% |